ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Washington » Internal Medicine

Top Internal Medicine Prescribers in Washington

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
LAIRD FINDLAY MD

Internal Medicine

9,674

$465K

634
561 are 65+

6%
patients receiving schedule two controlled substances

Avg: 7%

14%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 23%

$48
Average prescription price

Avg: $56

MICHAEL PARISOT MD

Internal Medicine

9,654

$541K

399
349 are 65+

7%
patients receiving schedule two controlled substances

Avg: 7%

24%
patients receiving schedule three controlled substances

Avg: 10%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$56
Average prescription price

Avg: $56

BRUCE BARGA MD

Internal Medicine

9,595

$438K

365
325 are 65+

12%
patients receiving schedule two controlled substances

Avg: 7%

20%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$46
Average prescription price

Avg: $56

JOHN LANK MD

Internal Medicine

9,522

$549K

508
412 are 65+

12%
patients receiving schedule two controlled substances

Avg: 7%

15%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 23%

$58
Average prescription price

Avg: $56

MARIA KOSCINSKA M.D.

Internal Medicine

9,515

$468K

497
427 are 65+

10%
patients receiving schedule two controlled substances

Avg: 7%

14%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$49
Average prescription price

Avg: $56

MANDEEP SAINI MD

Internal Medicine

9,492

$549K

649
523 are 65+

10%
patients receiving schedule two controlled substances

Avg: 7%

11%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 23%

$58
Average prescription price

Avg: $56

CLARK PARRISH M.D.

Internal Medicine

9,477

$405K

531
455 are 65+

10%
patients receiving schedule two controlled substances

Avg: 7%

13%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$43
Average prescription price

Avg: $56

BICH-KHANH NGUYEN M.D.

Internal Medicine

9,454

$533K

617
564 are 65+

11%
patients receiving schedule two controlled substances

Avg: 7%

14%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 23%

$56
Average prescription price

Avg: $56

PURNIMA PATEL M.D.

Internal Medicine

9,413

$470K

467
411 are 65+

7%
patients receiving schedule two controlled substances

Avg: 7%

13%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$50
Average prescription price

Avg: $56

EMAD ABU-KHIERAN MD

Internal Medicine

9,412

$736K

473
395 are 65+

4%
patients receiving schedule two controlled substances

Avg: 7%

15%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 23%

$78
Average prescription price

Avg: $56

JONG-WOOK BAN M.D.

Internal Medicine

9,411

$565K

566
436 are 65+

5%
patients receiving schedule two controlled substances

Avg: 7%

13%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 23%

$60
Average prescription price

Avg: $56

CRAIG ROMNEY MD

Internal Medicine

9,387

$413K

284
221 are 65+

17%
patients receiving schedule two controlled substances

Avg: 7%

27%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$44
Average prescription price

Avg: $56

ANNA MADEJ M. D.

Internal Medicine

9,379

$453K

368
325 are 65+

10%
patients receiving schedule two controlled substances

Avg: 7%

17%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$48
Average prescription price

Avg: $56

TIMOTHY GARDNER MD

Internal Medicine

9,356

$501K

471
391 are 65+

6%
patients receiving schedule two controlled substances

Avg: 7%

16%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 23%

$54
Average prescription price

Avg: $56

MICHAEL WILCOX M.D.

Internal Medicine

9,230

$443K

353
312 are 65+

8%
patients receiving schedule two controlled substances

Avg: 7%

14%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$48
Average prescription price

Avg: $56

JEFFREY CLODE MD

Internal Medicine

9,226

$437K

449
413 are 65+

5%
patients receiving schedule two controlled substances

Avg: 7%

15%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$47
Average prescription price

Avg: $56

ALEXANDER CHOW MD

Internal Medicine

9,201

$427K

463
397 are 65+

8%
patients receiving schedule two controlled substances

Avg: 7%

14%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$46
Average prescription price

Avg: $56

ROBERT ORY MD

Internal Medicine

9,163

$518K

535
452 are 65+

4%
patients receiving schedule two controlled substances

Avg: 7%

8%
patients receiving schedule three controlled substances

Avg: 10%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 23%

$57
Average prescription price

Avg: $56

KINGMAN HO MD

Internal Medicine

9,110

$683K

385
349 are 65+

8%
patients receiving schedule two controlled substances

Avg: 7%

15%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 23%

$75
Average prescription price

Avg: $56

ALAIN LAMBERT MD

Internal Medicine

9,099

$471K

658
589 are 65+

4%
patients receiving schedule two controlled substances

Avg: 7%

9%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$52
Average prescription price

Avg: $56

WALLACE HODGES MD

Internal Medicine

9,073

$764K

287
167 are 65+

38%
patients receiving schedule two controlled substances

Avg: 7%

11%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$84
Average prescription price

Avg: $56

JEFFERY CLARKE MD

Internal Medicine

9,061

$531K

446
397 are 65+

7%
patients receiving schedule two controlled substances

Avg: 7%

18%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$59
Average prescription price

Avg: $56

JOHANNA WANG MD

Internal Medicine

8,938

$449K

586
466 are 65+

9%
patients receiving schedule two controlled substances

Avg: 7%

13%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 23%

$50
Average prescription price

Avg: $56

JOANNE LYNN PEREZ M.D.

Internal Medicine

8,920

$444K

360
332 are 65+

8%
patients receiving schedule two controlled substances

Avg: 7%

21%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 23%

$50
Average prescription price

Avg: $56

JUDE GERARD VERZOSA MD

Internal Medicine

8,887

$516K

438
388 are 65+

8%
patients receiving schedule two controlled substances

Avg: 7%

14%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 23%

$58
Average prescription price

Avg: $56

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank